Clinical Trials Sponsored by King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Total 744 results

Acura Pharmaceuticals Inc.
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Completed

Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users

Opioid Abuse

United States
University of Vigo
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Completed

Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension (HYCCRA)

Hypertension

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

Depressive Disorder | Depression | Depressive Disorder, Major

Colombia, Mexico, United States, Peru, Chile, Argentina
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis (DOTAR)

Rheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis

Psoriatic Arthritis

France, Belgium, Korea, Republic of, Netherlands, United Kingdom, Germany, Taiwan, Portugal, Denmark, Saudi Arabia, Czechia, Sweden, Switzerland, Argentina, Poland, Italy, Hungary, Spain, Australia, Austria, Colombia, Finland, Former... and more
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder

Schizophrenia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents

Allergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Single Doses of GAP-134

Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Advanced Malignant Solid Tumors
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Study To Evaluate Methods To Evaluate Back Pain

Pain

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures

Fractures

Australia, Canada, United States, Sweden, Serbia, Spain, France, Germany, Mexico, Slovenia, Argentina, India, United Kingdom, Romania, Brazil, Finland, Latvia, Poland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

Fractures

Australia, United States, Finland, Canada, France, Germany, United Kingdom, Hungary, Norway, Sweden
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

Fibromyalgia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

Plaque Psoriasis | Nail Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Count Coughs in Subjects With Acute Upper Respiratory Tract Infections

Infection

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants

Meningitis, Meningococcal
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Bifeprunox in Patients With Schizophrenia.

Schizophrenia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis

Gastroesophageal Reflux | Esophagitis

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Kidney Transplant

Spain, Italy, Argentina, Greece, Taiwan, Singapore, United States, Canada, United Kingdom, Chile, South Africa, Hungary, Turkey, Austria, Germany, France, Norway, Australia, Sweden, Portugal, Cyprus
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia

Cross Infection | Bacterial Pneumonia | Community-Acquired Infections
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection

Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

Peptic Ulcer Hemorrhage

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections

Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Liver Transplantation in Haemophilia Patients in Spain

Hemophilia B | Hemophilia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females

Healthy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis

Ankylosing Spondylitis

France, Poland, Italy, Germany, Spain, United Kingdom, Denmark, Austria, China, Ireland, Hungary, Finland, Netherlands, Australia, Czech Republic, Qatar, Saudi Arabia, Sweden
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

Bacterial Infections | Skin Diseases, Infectious | Skin Diseases, Bacterial | Pneumonia, Bacterial | Intra-Abdominal Infection

Taiwan, United States, South Africa, Belgium, Mexico, Ukraine
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children

Pneumococcal Infections

Poland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

Vaccines, Pneumococcal

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Inhibitor Specificity in Hemophilia A

Hemophilia A

Belgium, Italy, Spain, United States, United Kingdom, Germany, France
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Community Acquired Bacterial Pneumonia | Complicated Intra-Abdominal Infection
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects

Skin Diseases | Infection
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women

Depressive Disorder | Depression | Depressive Disorder, Major

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pantoprazole in Children With GERD

Gastroesophageal Reflux

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy

Pain | Diabetic Neuropathies

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondylitis, Ankylosing | Ankylosing Spondylitis

Greece
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS

Pneumococcal Vaccines

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

Pneumococcal Vaccine

Korea, Republic of
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects

Community-Acquired Infections

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

Graft Rejection | Kidney Failure

United States, Spain, Canada, Switzerland, Austria, Australia, New Zealand
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Doses of ILV-095 in Healthy Japanese Male Subjects

Healthy Subjects

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

Vaccines, Pneumococcal Conjugate Vaccine

South Africa
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Tigecycline In-Vitro Surveillance Study In Taiwan

Community Acquired Infections

China
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis

Psoriasis

United States, Hong Kong, Canada, South Africa
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Kidney Transplantation | Graft Rejection | Kidney Failure
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Refacto For Pharmacovigilance

Hemophilia A

Germany, Austria
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl

Depression

United States

Clinical Trials Sponsored by King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations